Pharmacon Healthcare India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-01-2025
- Paid Up Capital ₹ 1.00 M
as on 03-01-2025
- Company Age 7 Year, 21 Days
- Last Filing with ROC 31 Mar 2020
- Revenue 72.24%
(FY 2020)
- Profit 75.41%
(FY 2020)
- Ebitda 123.51%
(FY 2020)
- Net Worth -2.49%
(FY 2020)
- Total Assets -5.13%
(FY 2020)
About Pharmacon Healthcare India
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Deepak Gupta and Narinder Kumar serve as directors at the Company.
- CIN/LLPIN
U74999CH2017PTC041813
- Company No.
041813
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Dec 2017
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- LocationChandigarh, Chandigarh
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Pharmacon Healthcare India Private Limited offer?
Pharmacon Healthcare India Private Limited offers a wide range of products and services, including Mineral Supplement, Ferrous Ascorbate Tablet.
Who are the key members and board of directors at Pharmacon Healthcare India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Gupta  | Director | 27-Dec-2017 | Current |
| Narinder Kumar | Director | 27-Dec-2017 | Current |
Financial Performance of Pharmacon Healthcare India.
Pharmacon Healthcare India Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 72.24% increase. The company also saw a substantial improvement in profitability, with a 75.41% increase in profit. The company's net worth dipped by a decrease of 2.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmacon Healthcare India?
Unlock access to Pharmacon Healthcare India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmacon Healthcare India?
Unlock and access historical data on people associated with Pharmacon Healthcare India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmacon Healthcare India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmacon Healthcare India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
